Genetic testing for commonly occurring oncogenes associated with breast cancer—specifically BRCA1 and BRCA2—is progressively becoming a standard procedure in numerous African countries for patients diagnosed with breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.